MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,538 Cr | ₹848 Cr | ₹576 Cr | ₹388 Cr | ₹331 Cr |
What is the latest Sundry Debtors ratio of MANKIND PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹1,538 Cr |
| Mar2024 | ₹848 Cr |
| Mar2023 | ₹576 Cr |
| Mar2022 | ₹388 Cr |
| Mar2021 | ₹331 Cr |
How is Sundry Debtors of MANKIND PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,538 Cr | 81.35 | |
| Mar2024 | ₹848 Cr | 47.16 | |
| Mar2023 | ₹576 Cr | 48.50 | |
| Mar2022 | ₹388 Cr | 17.41 | |
| Mar2021 | ₹331 Cr | - | |
Compare Sundry Debtors of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,591.0 Cr | -0.1% | -8.3% | -14% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.1% |
-8.3% |
-14% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses